Anna Santamaria

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications

BORA overexpression promotes epithelial-mesenchymal transition and metastasis in ovarian cancer: Unveiling a novel therapeutic target for advanced disease.

BORA overexpression promotes epithelial-mesenchymal transition and metastasis in ovarian cancer: Unveiling a novel therapeutic target for advanced disease.

Journal: Clinical and translational medicine
Published: December 19, 2024

Circulating tumor extracellular vesicles to monitor metastatic prostate cancer genomics and transcriptomic evolution.

Circulating tumor extracellular vesicles to monitor metastatic prostate cancer genomics and transcriptomic evolution.

Journal: Cancer cell
Published: August 24, 2023

Accurate diagnosis of prostate cancer by combining Proclarix with magnetic resonance imaging.

Accurate diagnosis of prostate cancer by combining Proclarix with magnetic resonance imaging.

Journal: BJU international
Published: March 01, 2023

Overcoming Paradoxical Kinase Priming by a Novel MNK1 Inhibitor.

Overcoming Paradoxical Kinase Priming by a Novel MNK1 Inhibitor.

Journal: Journal of medicinal chemistry
Published: April 13, 2022

Comparative Analysis of PSA Density and an MRI-Based Predictive Model to Improve the Selection of Candidates for Prostate Biopsy.

Comparative Analysis of PSA Density and an MRI-Based Predictive Model to Improve the Selection of Candidates for Prostate Biopsy.

Journal: Cancers
Published: April 06, 2022

Comparison of Proclarix, PSA Density and MRI-ERSPC Risk Calculator to Select Patients for Prostate Biopsy after mpMRI.

Comparison of Proclarix, PSA Density and MRI-ERSPC Risk Calculator to Select Patients for Prostate Biopsy after mpMRI.

Journal: Cancers
Published: March 29, 2022

Multiparametric Magnetic Resonance Imaging Grades the Aggressiveness of Prostate Cancer.

Multiparametric Magnetic Resonance Imaging Grades the Aggressiveness of Prostate Cancer.

Journal: Cancers
Published: March 07, 2022

Who with suspected prostate cancer can benefit from Proclarix after multiparametric magnetic resonance imaging?

Who with suspected prostate cancer can benefit from Proclarix after multiparametric magnetic resonance imaging?

Journal: The International journal of biological markers
Published: February 24, 2022

The Barcelona Predictive Model of Clinically Significant Prostate Cancer.

The Barcelona Predictive Model of Clinically Significant Prostate Cancer.

Journal: Cancers
Published: February 24, 2022

Improving the Early Detection of Clinically Significant Prostate Cancer in Men in the Challenging Prostate Imaging-Reporting and Data System 3 Category.

Improving the Early Detection of Clinically Significant Prostate Cancer in Men in the Challenging Prostate Imaging-Reporting and Data System 3 Category.

Journal: European urology open science
Published: December 21, 2021

Loss of microRNA-135b Enhances Bone Metastasis in Prostate Cancer and Predicts Aggressiveness in Human Prostate Samples.

Loss of microRNA-135b Enhances Bone Metastasis in Prostate Cancer and Predicts Aggressiveness in Human Prostate Samples.

Journal: Cancers
Published: November 21, 2021

The Efficacy of Proclarix to Select Appropriate Candidates for Magnetic Resonance Imaging and Derived Prostate Biopsies in Men with Suspected Prostate Cancer.

The Efficacy of Proclarix to Select Appropriate Candidates for Magnetic Resonance Imaging and Derived Prostate Biopsies in Men with Suspected Prostate Cancer.

Journal: The world journal of men's health
Published: July 08, 2021
Showing 1-12 of 33

Last Updated: 09/26/2026